Heidenreich K A, Brandenburg D
Endocrinology. 1986 May;118(5):1835-42. doi: 10.1210/endo-118-5-1835.
We tested the hypothesis that the molecular weight discrepancy between insulin receptors in brain and adipocytes is due to differences in glycosylation by treating photoaffinity-labeled insulin receptors from both tissues with endo-beta-N-acetylglucosaminidase F (Endo F) and analyzing the products by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Endo F removed glycans from the adipocyte 125-kilodalton (kDa) subunit and the brain 115-kDa subunit in a manner dependent upon the concentration of enzyme and time of incubation. At a maximally effective concentration of Endo F, the adipocyte alpha-subunit was reduced from 125-kDa to 100-kDa and the brain alpha-subunit from 115-kDa to 100-kDa. We also examined the type of oligosaccharides present in both alpha-subunits by treating the proteins with endo-beta-N-acetylglucosaminidase H (Endo H), which selectively removes high mannose residues, and neuraminidase. Endo H treatment reduced the apparent molecular weight of both the adipocyte and brain alpha-subunits. In both receptors, the deglycosylated product obtained with Endo H was larger than that generated by Endo F. The adipocyte alpha-subunit demonstrated a shift in mobility on sodium dodecyl sulfate gels after neuraminidase treatment, whereas the brain alpha-subunit did not. We conclude from these studies that 1) The discrepancy in apparent molecular weight of alpha-subunits in brain and adipocytes is due to differences in N-linked glycosylation; 2) high mannose and complex type oligosaccharides are present in both receptor types; and 3) the complex oligosaccharides in the adipocyte alpha-subunit are terminated in a manner different from the complex glycans of the brain alpha-subunit.
我们通过用内切β-N-乙酰葡糖胺酶F(Endo F)处理来自两种组织的光亲和标记胰岛素受体,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析产物,来检验大脑和脂肪细胞中胰岛素受体之间分子量差异是由于糖基化差异所致的假说。Endo F以依赖于酶浓度和孵育时间的方式从脂肪细胞125千道尔顿(kDa)亚基和大脑115-kDa亚基上去除聚糖。在Endo F的最大有效浓度下,脂肪细胞α-亚基从125-kDa降至100-kDa,大脑α-亚基从115-kDa降至100-kDa。我们还通过用内切β-N-乙酰葡糖胺酶H(Endo H)处理蛋白质来检查两种α-亚基中存在的寡糖类型,Endo H可选择性去除高甘露糖残基,以及用神经氨酸酶处理。Endo H处理降低了脂肪细胞和大脑α-亚基的表观分子量。在两种受体中,用Endo H获得的去糖基化产物都比Endo F产生的产物大。神经氨酸酶处理后,脂肪细胞α-亚基在十二烷基硫酸钠凝胶上的迁移率发生了变化,而大脑α-亚基则没有。我们从这些研究中得出结论:1)大脑和脂肪细胞中α-亚基表观分子量的差异是由于N-连接糖基化的差异;2)两种受体类型中都存在高甘露糖和复合型寡糖;3)脂肪细胞α-亚基中的复合寡糖的末端连接方式与大脑α-亚基的复合聚糖不同。